12 Recruiting Clostridioides Difficile Infection Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Recruiting Clostridioides Difficile Infection Studies
🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
LMN-201 for Prevention of C. Difficile Infection Recurrence
📍 Kaiser Permanente — Escondido, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Observational / Diagnostic 📋 Clinical Research Protocol
Evaluation of GeoHAI Implementation
📍 The Ohio State University — Columbus, Ohio
View Study & Checklist ➔ 🟡 Not Yet Recruiting Early Phase1 💊 Investigational Drug / Biologic
Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy
📍 Daniel Stein — Milwaukee, Wisconsin
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol
Lifestyle and Recurrent Clostridioides Difficile Infection (CDI)
📍 University of Michigan — Ann Arbor, Michigan
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
📍 UVA Health Systems — Charlottesville, Virginia
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
Secondary Prevention of Clostridioides Difficile Using Vancomycin
📍 McGill University Health Centre — Montreal, Quebec
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
📍 Research Site — Phoenix, Arizona
View Study & Checklist ➔